(this page not finished yet)
Feng JQ. Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism. Nat Genet 2006;38(11):1310-5.
Khandwala HM. Low serum alkaline phosphatase activity and pathologic fracture: case report and brief review of hypophosphatasia diagnosed in adulthood. Endocr Pract 2006;12(6):676-81.
Lorenz-Depiereux B. DMP1 mutations in autosomal recessive hypophosphatemia implicate a bone matrix protein in the regulation of phosphate homeostasis. Nat Genet 2006;38(11):1248-50.
Whyte MP. Marrow cell transplantation for infantile hypophosphatasia. J Bone Miner Res 2003;18(4):624-36.
Whyte MP. Adult Hypophosphatasia Treated with Teriparatide. J Clin Endocrinol Metab 2007.
Berman E. Altered bone and mineral metabolism in patients receiving imatinib mesylate. N Engl J Med 2006;354(19):2006-13.
Bowe AE. FGF-23 inhibits renal tubular phosphate transport and is a PHEX substrate. Biochem Biophys Res Commun 2001;284:977-81.
Carpenter TO. Oncogenic osteomalacia--a complex dance of factors. N Engl J Med 2003;348:1705-8.
Jonsson KB. Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia. N Engl J Med 2003;348:1656-63.
Quarles LD. FGF23, PHEX, and MEPE regulation of phosphate homeostasis and skeletal mineralization. Am J Physiol Endocrinol Metab 2003;285:E1-9.
Updated 3/23/07